Table 3:
Patient Characteristics for all Patients with CCTA-detected CAD According to Guideline Recommendation
| Characteristic | Aspirin not recommended | Aspirin recommended | Statins not recommended | Statins recommended |
|---|---|---|---|---|
| N=68 | N=99 | N = 99 | N = 63 | |
| Mean Age (years) | 53.5 ± 9.0 | 60.9 ± 12.1 | 57.7 ± 10.8 | 59.0 ± 12.4 |
| Male sex – n (%) | 36 (53) | 78 (79) | 64 (65) | 45 (71) |
| Hypertension – n (%) | 30 (44) | 60 (63) | 51 (52) | 36 (57) |
| Smoking – n (%) | 32 (47) | 66 (67) | 58 (59) | 37 (59) |
| Diabetes Mellitus – n (%) | 1 (1) | 25 (25) | 7 (7) | 18 (29) |
| Vascular Disease (TIA/CVA/PAD) – n (%) | 0 (0) | 6 (6) | 0 (0) | 6 (10) |
| Acute Coronary Syndrome - n (%) | 0 (0) | 31 (31) | 3 (3) | 26 (41) |
| FRS category, n (%) | ||||
| <10% | 68 (100) | 28 (28) | 67 (68) | 27 (43) |
| 10% –20 % | 0 (0) | 49 (49) | 26 (26) | 20 (32) |
| >20% | 0 (0) | 21 (21) | 5 (5) | 16 (25) |
| Dyslipidemia – n (%) | 36 (53) | 51 (52) | 53 (54) | 31 (49) |
| Total Cholesterol (mg/dl) | 196 ± 42 | 190 ± 47 | 182 ± 42 | 208 ± 46 |
| LDL Cholesterol (mg/dl) | 116 ± 36 | 109 ± 36 | 103 ± 32 | 125 ± 38 |
| HDL Cholesterol (mg/dl) | 53 ± 16 | 45 ± 12 | 50 ± 15 | 47 ± 12 |
*
Plus-minus values are means ± SD.
TIA: Transient Ischemic Attack, CVA: Cerebrovascular Accident, PAD: Peripheral Arterial Disease, FRS: 10-year Framingham Risk Score